Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Twist Bioscience Corp
(NQ:
TWST
)
43.24
-1.66 (-3.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corp
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Earnings Scheduled For February 2, 2024
February 02, 2024
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion.
Via
Benzinga
Twist Bioscience Earnings Preview
February 01, 2024
Via
Benzinga
Twist Bioscience Corp Daily Investment Opportunity
January 25, 2024
Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries.
Via
Talk Markets
Twist Bioscience Expands Express Genes Rapid Synthesis Service
January 24, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corp. (NASDAQ: TWST) Near the Top of Equities by Percentage Gain on 11/17
November 17, 2023
Via
Investor Brand Network
Twist Bioscience: Q4 Earnings Insights
November 17, 2023
Via
Benzinga
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
January 17, 2024
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing...
Via
Benzinga
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
January 16, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Biotech Playbook: Small Caps Show Momentum Peaking During
January 15, 2024
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.
Via
Talk Markets
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
January 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
January 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
3 Genomics Stocks to Unlock the Future of Medicine
December 19, 2023
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
Via
InvestorPlace
Exposures
Product Safety
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 18, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout
December 12, 2023
While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same.
Via
Talk Markets
Biotech Is Coming Back, Can The Run Last?
December 11, 2023
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally.
Via
Talk Markets
Five Best Performing Stocks Of The Top ETF Of November
December 01, 2023
Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way.
Via
Talk Markets
Topics
ETFs
Cramer Says No To This EV Maker, But Recommends This Major Automaker Stock: It 'Goes Up And Up'
November 21, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said no to Lucid Group, Inc.
Via
Benzinga
S&P 500 Edges Higher; Buckle Shares Surge After Q3 Earnings
November 17, 2023
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 30 points on Friday. The Dow traded up 0.07% to 34,969.63 while the NASDAQ rose 0.21% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 17, 2023
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via
Benzinga
Crude Oil Rises Over 3%; BJ's Wholesale Posts Weak Sales
November 17, 2023
U.S. stocks traded mostly flat midway through trading on Friday. The Dow traded up 0.01% to 34,945.78 while the NASDAQ fell 0.03% to 14,109.53. The S&P 500 also rose, gaining, 0.05% to 4,510.71.
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
November 17, 2023
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DNA-Maker Twist Bioscience Catapults 21% As 'Solid' Outlook That Tops Its Peers
November 17, 2023
The company expects sales to grow 16% to 18% in fiscal year 2024, which is already underway.
Via
Investor's Business Daily
Why Synthetic DNA Company Twist Bioscience Shares Are Jumping Today
November 17, 2023
Twist Bioscience Corp's (NASDAQ: TWST) Q4 sales increased 16.8% Y/Y to $66.9 million,
Via
Benzinga
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
November 17, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
November 14, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
November 13, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 08, 2023
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
November 02, 2023
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.